Australian Clinical Labs Limited (ACL.AX)
ASX · AUD · Healthcare · Diagnostics & Research
A$2.96 (-0.67%) as of
Key statistics
- Market cap
- 552.10M
- P/E (TTM)
- 24.67
- Forward P/E
- 14.54
- EPS (TTM)
- 0.1200
- Dividend yield
- 4.36%
- 52-week range
- 1.8325 – 3.0300
- Beta
- 0.82
- Revenue (TTM)
- 736.15M
- Profit margin
- 3.22%
- Analyst target
- A$2.79
- Volume
- 247.74k
About Australian Clinical Labs Limited
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers cardiac testing, gastroenterology, haematology, chemical pathology, antenatal testing, serology and microbiology, cervical screening, commercial drug and alcohol testing, STI Testing, veterinary pathology, molecular cancer services, clinical trials pathology, advanced genetic testing, functional pathology, histopathology and cytopathology, CPD education programs for clinicians, and allergy and immunology services. It also provides workplace services, environmental screening, and clinical trial services. The company offers its services under the SunDoctors, SouthernSun Pathology, Specialised Trials, BeFunctional Labs, and Gribbles Veterinary Pathology brands. It serves doctors, patients, and corporate clients. The company was founded in 2015 and is headquartered in Clayton, Australia.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Clayton, VIC, Australia
- Employees
- 4,500
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.